ARIPiprazole
Drug Name | Form | Strength | Infusion Center Available | Restricted | Non-formulary | Ambulatory Available | Interchange | REMS |
---|---|---|---|---|---|---|---|---|
Abilify Maintena | POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR | 300 mg; 400 mg | ||||||
Abilify Maintena Prefilled Syringe | POWDER FOR INJECTION, EXTENDED RELEASE, INTRAMUSCULAR | 400 mg | ||||||
Abilify | SOLUTION, ORAL | 1 mg/mL | ||||||
Aristada | SUSPENSION, EXTENDED RELEASE, INTRAMUSCULAR | 441 mg/1.6 mL, 662 mg/2.4 mL, 882 mg/3.2 mL, 1064 mg/3.9 mL | ||||||
Aristada Initio | SUSPENSION, EXTENDED RELEASE, INTRAMUSCULAR | 675 mg/2.4 mL, 1064 mg/3.9 mL | ||||||
Abilify Asimtufii | SUSPENSION, EXTENDED RELEASE, INTRAMUSCULAR | 720 mg/2.4 mL, 960 mg/3.2 mL | ||||||
Abilify | TABLET, ORAL | 2 mg; 5 mg; 10 mg; 15 mg; 30 mg | ||||||
Aripiprazole | TABLET, ORAL | 20 mg |
Abilify Maintena, Aristada/Aristada Initio, Abilify Asimtufii: OHS Inpatient Hospital Pharmacy Free Drug Trial Program (Long-Acting Injectable Antipsychotics)
*Abilify Asimtufii: Any inpatient use outside of the hospital free drug program is considered non-formulary